Altria Sues FDA to Overhaul Stalled Tobacco Product Review System

Marlboro manufacturer Altria has filed a federal lawsuit against the US Food and Drug Administration in Lubbock, Texas, demanding a court-ordered replacement of the agency’s tobacco review process. The lawsuit alleges that bureaucratic inertia has paralyzed compliant domestic companies while unauthorized foreign products capture market share.

Lawsuit Challenges Broken 180-Day Review Mandate

Under federal law, the FDA must evaluate new tobacco products before they enter the market, determining whether they offer a net public health benefit. Statute requires the agency to issue determinations within 180 days of receiving an application. Altria’s legal filing states the agency has consistently failed to meet this statutory timeline.

Altria and co-plaintiffs, including the Texas Food and Fuel Association, argue that this regulatory bottleneck unfairly penalizes manufacturers attempting to follow federal rules. The complaint highlights that products such as On! nicotine pouches remain trapped in review, even under fast-track pathways that missed target completion dates set for December 2025.

Read more: Federal Court Limits FDA Authority Over Cigarette Warnings and PMTA Denials

Multi-Year Delays Fuel Market Disruption

The FDA’s pre-market tobacco application (PMTA) process has faced intense criticism across the industry. While the agency has rejected tens of millions of product filings, other applications have languished in review queues for more than six years. This backlog directly affects major manufacturers, including Altria, Philip Morris International, and British American Tobacco.

Public health advocates argue that rigorous review protocols prevent youth nicotine uptake. However, tobacco manufacturers contend the current enforcement imbalance has created an unlevel playing field. While domestic products await formal authorization, illicit disposable vapes and unauthorized imports continue to enter retail channels.

The lawsuit represents an escalation following industry outreach to the Trump administration. Tobacco companies have pushed for administrative reforms, seeking faster clearance pathways for smoke-free nicotine products and revised enforcement priorities against unapproved devices.

Read more: FDA Authorizes New Juul Vape Device with Age-Gating Technology
Source: Altria sues FDA over tobacco product review system

Author
Recent Posts

Matthew Ma

Marketing at Ecigator

With over a decade of experience in the e-cigarette industry, Matthew Ma is a seasoned expert in both the manufacturing and usage aspects of vaping products. His extensive background has provided him with a deep understanding of the intricacies and evolving dynamics of e-cigarettes.